blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3270937

EP3270937 - ANTI-MICA ANTIGEN BINDING FRAGMENTS, FUSION MOLECULES, CELLS WHICH EXPRESS AND METHODS OF USING [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  11.10.2019
Database last updated on 08.04.2026
FormerRequest for examination was made
Status updated on  28.12.2017
FormerThe international publication has been made
Status updated on  10.10.2017
Most recent event   Tooltip17.03.2025New entry: Renewal fee paid 
Applicant(s)For all designated states
The Trustees Of Dartmouth College
11 Rope Ferry Road
Room 6210
Hanover, NH 03755 / US
[2018/04]
Inventor(s)01 / SENTMAN, Charles
11 Pearl Street
West Lebanon, New Hampshire 03784 / US
02 / BATTLES, Michael
705 Canaan Street
Canaan, New Hampshire 03741 / US
 [2018/04]
Representative(s)Page White Farrer
Bedford House
21a John Street
London WC1N 2BF / GB
[N/P]
Former [2018/04]Stephens, Clare Jean
Page White & Farrer
Bedford House
John Street
London WC1N 2BF / GB
Application number, filing date16769806.725.03.2016
[2018/04]
WO2016US24322
Priority number, dateUS201562138561P26.03.2015         Original published format: US 201562138561 P
[2018/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016154585
Date:29.09.2016
Language:EN
[2016/39]
Type: A1 Application with search report 
No.:EP3270937
Date:24.01.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 29.09.2016 takes the place of the publication of the European patent application.
[2018/04]
Search report(s)International search report - published on:US29.09.2016
(Supplementary) European search report - dispatched on:EP16.08.2018
ClassificationIPC:A61K35/17, A61K39/395, C07K16/28, C12N5/10, C12P21/08, A61P35/00
[2018/37]
CPC:
C07K16/2809 (EP,US); C07K16/2851 (EP,US); A61K40/11 (EP,US);
A61K40/31 (EP,US); A61K40/4202 (EP,US); A61K47/6835 (US);
A61K51/1045 (US); A61K51/1096 (US); A61P35/00 (EP,US);
C07K16/2833 (EP,US); A61K2039/505 (US); C07K2317/31 (EP,US);
C07K2317/622 (EP,US); C07K2319/03 (EP,US) (-)
Former IPC [2018/04]A61K35/17, A61K39/395, C07K16/28, C12N5/10, C12P21/08
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/04]
TitleGerman:FRAGMENTE ZUR BINDUNG DES ANTI-MICA-ANTIGENS, FUSIONSMOLEKÜLE, EXPRESSIONSZELLEN UND VERFAHREN ZUR VERWENDUNG[2018/04]
English:ANTI-MICA ANTIGEN BINDING FRAGMENTS, FUSION MOLECULES, CELLS WHICH EXPRESS AND METHODS OF USING[2018/04]
French:FRAGMENTS DE LIAISON À L'ANTIGÈNE ANTI-MICA, MOLÉCULES HYBRIDES, CELLULES EXPRIMANT CEUX-CI ET PROCÉDÉS D'UTILISATION[2018/04]
Entry into regional phase19.10.2017National basic fee paid 
19.10.2017Search fee paid 
19.10.2017Designation fee(s) paid 
19.10.2017Examination fee paid 
Examination procedure19.10.2017Examination requested  [2018/04]
19.10.2017Date on which the examining division has become responsible
14.03.2019Amendment by applicant (claims and/or description)
15.10.2019Despatch of a communication from the examining division (Time limit: M06)
24.04.2020Reply to a communication from the examining division
16.07.2021Despatch of a communication from the examining division (Time limit: M04)
22.11.2021Reply to a communication from the examining division
22.03.2024Despatch of a communication from the examining division (Time limit: M06)
19.09.2024Reply to a communication from the examining division
Fees paidRenewal fee
23.03.2018Renewal fee patent year 03
26.03.2019Renewal fee patent year 04
13.03.2020Renewal fee patent year 05
11.03.2021Renewal fee patent year 06
03.03.2022Renewal fee patent year 07
17.02.2023Renewal fee patent year 08
14.02.2024Renewal fee patent year 09
17.03.2025Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X] WO2011090762  (EMERGENT PRODUCT DEV SEATTLE et al.) [X] 1-3,5,8,9,11-14 * sequence 319 * * page 87 - page 90; example 4 * * page 31, line 12 *
 [IA] WO2013049517  (DANA FARBER CANCER INST INC et al.) [I] 1-3 * page 27 - page 29; table 1 * * page 69, line 1 - page 70, line 9; example 5 * * page 68, lines 15-17 * * example 9 * * example 11 *[A] 4-15
 [IA] WO2013117647  (INNATE PHARMA et al.) [I] 1-3 * page 114, line 4 - page 115, line 33; example 2 * * page 125 - page 127; example 5 *[A] 4-15
 [I] WO2014144791  (DANA FARBER CANCER INST INC et al.) [I] 4,6,7,10,15 * page 25 - page 26; table 1 * * page 7, line 4 - page 10, line 4 * * page 54, lines 6-32 * * claims 23-35 *
 [XA]   HIRSCH R ET AL: "EFFECTS OF IN-VIVO ADMINISTRATION OF ANTI-T3 MONOCLONAL ANTIBODY ON T CELL FUNCTION IN MICE I. IMMUNOSUPPRESSION OF TRANSPLANTATION RESPONSES", JOURNAL OF IMMUNOLOGY, vol. 140, no. 11, 1988, pages 3766 - 3772, XP002783591, ISSN: 0022-1767 [X] 1,2 * the whole document * [A] 3-15
International search[XY] US2011091372  (GHAYUR TARIQ et al.) [X] 1-3, 5, 37, 49-51 * entire document *[Y] 42, 44
 [XY] WO2014117121  (ST JUDE CHILDRENS RES HOSPITAL et al.) [X] 19, 73 * entire document *[Y] 42, 44
 [X] US2010272718  (URSO BIRGITTE et al.) [X] 63, 64 * entire document *
 [A] WO2013117647  (INNATE PHARMA et al.) [A] 1-5, 19, 37, 42-44, 49-51, 63, 64, 73 * entire document *
 [A] CN102911270  (UNIV ZHEJIANG et al.) [A] 1-5, 19, 37, 42-44, 49-51, 63, 64, 73 * entire documen see machine translation *
Examination  DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; July 2017 (2017-07-01), GODBERSEN CLAIRE ET AL: "NKG2D Ligand-Targeted Bispecific T-Cell Engagers Lead to Robust Antitumor Activity against Diverse Human Tumors", Database accession no. PREV201700650642
   MOLECULAR CANCER THERAPEUTICS, vol. 16, no. 7, July 2017 (2017-07-01), pages 1335 - 1346, ISSN: 1535-7163(print), DOI: 10.1158/1535-7163.MCT-16-0846 * the whole document *
by applicantWO2014144791
 WO2013117647
 WO2011090762
 WO2013049517
 WO2005061547
 WO2006113665
 WO2008157379
 WO2010080538
 WO2008122039
 US8192984
 WO2010119257
 US2005112095
 US5075109
 US4452775
 US4667014
 US4748034
 US5239660
 US3832253
 US3854480
 US4690915
 US5929212
   BURGESS ET AL., IMMUNOL. RES., vol. 40, 2008, pages 18 - 34
   JONJIC ET AL., EUR. J. IMMUNOL., vol. 38, 2008, pages 2927 - 68
   WROBEL ET AL., SCAND. J. IMMUNOL., vol. 66, 2007, pages 320 - 28
   SAEZ-BORDERIAS ET AL., EUR. J. IMMUNOL., vol. 36, 2006, pages 3198 - 06
   MENDOZA-RINCON ET AL.: "Manual Modemo", 2007, article "Advances in Cancer Research at UNAM", pages: 127 - 135
   PASCHEN ET AL., CLIN. CANCER RES., vol. 15, 2009, pages 5208 - 15
   UNNI ET AL., PROC. NATL. ACAD. SCI. USA, vol. 105, 2008, pages 1686 - 91
   KATO ET AL., LEUKEMIA, vol. 21, 2007, pages 2103 - 08
   CHALUPNY ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., vol. 346, 2006, pages 175 - 81
   TOSH ET AL., HUM. MOL. GENET., vol. 15, 2006, pages 2880 - 87
   SANTONI ET AL., AM. J. REPROD. IMMUNOL., vol. 58, 2007, pages 280 - 88
   PAPAZAHARIADOU ET AL., INT. J. BIOL. MARKERS, vol. 22, 2007, pages 144 - 53
   SALIH ET AL., HUM. IMMUNOL., vol. 67, 2006, pages 188 - 95
   MARTEN ET AL., INT. J. CANCER, vol. 119, 2006, pages 2359 - 65
   SALIH ET AL., FRONT. BIOSCI., vol. 4A, 2008, pages 2041 - 45
   HOLDENRIEDER ET AL., CANCER IMMUNOL. IMMUNOTHER., vol. 55, 2006, pages 1584 - 89
   MAY ET AL., J. CLIN. ONCOL., vol. 30, 2012
   BONNAFOUS ET AL., J. IMMUNOTHER. CANCER, vol. l, no. 1, 2013, pages 41
   JOURNAL OF IMMUNOLOGY, vol. 140, no. 11, 1988, pages 3766 - 3772
   AILOR ET AL., CURR. OPIN. BIOTECHNOL., vol. 10, 1999, pages 142 - 145
   HIATT ET AL., NATURE, vol. 342, 1989, pages 76 - 78
   HOUSTON ET AL., PROC. NATL. ACAD. SCI. USA, vol. 85, 1988, pages 5879 - 5883
   BIRD ET AL., SCIENCE, vol. 242, 1988, pages 423 - 426
   FELDHAUS ET AL., NATURE BIOTECHNOL., vol. 21, 2003, pages 163 - 170
   SIEGEL ET AL., J. IMMUNOL. METHODS, vol. 286, 2004, pages 141 - 53
   WEAVER-FELDHAUS ET AL., FEBSLETT., vol. 564, 2004, pages 24 - 34
   NEUBERGER ET AL., NATURE, vol. 312, 1984, pages 604 - 8
   NEUBERGER, TRENDS BIOCHEM. SCI., vol. 9, 1985, pages 347 - 9
   KING ET AL., BIOCHEM. J., vol. 290, 1993, pages 723 - 9
   RIECHMANN ET AL., J. MOL. BOIL., vol. 203, 1988, pages 825 - 8
   DORAI ET AL., BIOTECHNOLOGY (NY, vol. 12, 1994, pages 890 - 7
   JOST ET AL., J. BIOL. CHEM., vol. 269, 1994, pages 26267 - 73
   BEI ET AL., J. IMMUNOL. METHODS, vol. 186, 1995, pages 245 - 55
   CARAYANNOPOULOS ET AL., PROC. NATL. ACAD. SCI. USA, vol. 91, 1994, pages 8348 - 52
   HASEMANNCAPRA, PROC. NATL. ACAD. SCI. USA, vol. 87, 1990, pages 3942 - 6
   KRETZSCHMAR ET AL., J. IMMUNOL. METHODS, vol. 195, 1996, pages 93 - 101
   MAHIOUZ ET AL., J. IMMUNOL. METHODS, vol. 212, 1998, pages 149 - 160
   FISCHER ET AL., BIOTECHNOL. APPL. BIOCHEM., vol. 30, 1999, pages 113 - 6
   KUROIWA ET AL., NAT. BIOTECHNOL., vol. 20, 2002, pages 889 - 75
   LITTLE ET AL., IMMUNOL. TODAY, vol. 21, 2000, pages 364 - 70
   POLLOCK ET AL., J. IMMUNOL. METHODS, vol. 231, 1999, pages 147 - 157
   FRENKEN ET AL., RES. IMMUNOL., vol. 149, 1998, pages 589 - 599
   NYYSSONEN ET AL., BIOTECHNOLOGY (NY, vol. 11, 1993, pages 591 - 5
   FRENKEN ET AL.: "Biological Membranes: Structure Biogenesis and Dynamics", vol. H82, 1994, SPRINGER-VERLAG, pages: 223 - 236
   SOTIRIADIS ET AL., BIOTECHNOL. PROG., vol. 17, 2001, pages 618 - 23
   BAEUERLE ET AL., DRUGS OF THE FUTURE, vol. 33, 2008, pages 137 - 147
   BARGOU ET AL., SCIENCE, vol. 321, 2008, pages 974 - 977
   BAEUERLE ET AL., CURR. OPIN. MOL. THER., vol. 11, 2009, pages 22 - 30
   BRISCHWEIN ET AL., J. IMMUNOTHER., vol. 30, 2007, pages 798 - 807
   LEGALL ET AL., PROT. ENG. DESIGN SELECT, vol. 17, 2004, pages 357 - 366
   KOWOLIK ET AL., CANCER RES., vol. 66, 2006, pages 10995 - 11004
   ZHAO ET AL., J. IMMUNOL., vol. 183, 2009, pages 5563 - 5574
   PULE ET AL., MOL. THER., vol. 12, 2005, pages 933 - 941
   ZHONG ET AL., MOL. THER., vol. 18, 2010, pages 413 - 420
   "GENBANK", Database accession no. NP 003318
   WU ET AL., NAT. BIOTECHNOL., vol. 23, 2005, pages 1137 - 1146
   MARCU-MALINA ET AL., EXP. OPIN. BIOL. THER., vol. 9, 2009, pages 579 - 91
   BONINI ET AL., SCIENCE, vol. 276, 1997, pages 1719 - 1724
   THOMIS ET AL., BLOOD, vol. 97, 2001, pages 1249 - 1257
   GONZALEZ ET AL., J. GENE MED., vol. 6, 2004, pages 704 - 711
   TEY ET AL., BIOL. BLOOD MARROW TRANSPLANT, vol. 13, 2007, pages 913 - 24
   INTRONA ET AL., HUM. GENE THER., vol. 11, 2000, pages 611 - 20
   GRIFFIOEN ET AL., HAEMATOLOGICA, vol. 94, 2009, pages 1316 - 20
   TERAKURA ET AL., BLOOD, vol. 119, 2012, pages 72 - 82
   LANG ET AL., BLOOD, vol. 103, 2004, pages 3982 - 5
   CARPENITO ET AL., PROC. NATL. ACAD. SCI. USA, vol. 106, 2009, pages 3360 - 3365
   SONG ET AL., CANCER RES., vol. 71, 2011, pages 4617 - 4627
   PARENTE-PEREIRA ET AL., J. CLIN. IMMUNOL., vol. 31, 2011, pages 710 - 718
   ZHAO ET AL., CANCER RES., vol. 70, 2010, pages 9053 - 9061
   CANEVARI ET AL., J. NATL. CANCER INST., vol. 87, 1995, pages 1463 - 1469
   DUVAL ET AL., CLIN. CANCER RES., vol. 12, 2006, pages 1229 - 123680
   TOPALIANROSENBERG, ACTA HAEMATOL., vol. 78, no. 1, 1987, pages 75 - 6
   SHASTRIGONZALEZ, J. IMMUNOL., vol. 150, 1993, pages 2724 - 36
   ARAKAWA ET AL., J. BIOCHEM., vol. 120, 1996, pages 657 - 62
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.